Veterinary medicine

Europe Antibiotics Market Report 2021: Focus on Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, & Sulfonamides - Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 16, 2021
Health, Pharmaceutical, Health sciences, Health, Articles, Antibiotic resistance, Pharmaceuticals policy, Veterinary medicine, Antibiotic, Evolutionary biology, Pharmacy, Antimicrobial resistance, Infectious Diseases Society of America

The "Europe Antibiotics Market By Action Mechanism, By Drug Class, By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Antibiotics Market By Action Mechanism, By Drug Class, By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
  • Moreover, favorable government regulations like the Generating Antibiotics Incentives Now (GAIN) Act are estimated to speed up the approval process.
  • The rising numbers of patients who are suffering from infectious diseases lead to the growth of the antibiotics market.
  • The market research report covers the analysis of key stake holders of the market.

Recce Pharmaceuticals Announces Agreement with Fiona Stanley Hospital for a Phase 1/2 Clinical Trial Evaluating Topical Spray-On Antibiotic RECCE® 327 on Chronic Burn Wounds

Retrieved on: 
Tuesday, February 16, 2021
Articles, Health sciences, Pharmaceuticals policy, Antimicrobial resistance, Evolutionary biology, Veterinary medicine, Burn, Health

Our team is keen to identify and add new treatments with the potential to overcome antibiotic resistance and improve patients lives.

Key Points: 
  • Our team is keen to identify and add new treatments with the potential to overcome antibiotic resistance and improve patients lives.
  • The Phase 1/2 topical study will enroll up to 30 patients and be conducted at Fiona Stanley Hospital Burns Unit in Perth Western Australia.
  • Over 14 days, 10 patients will receive RECCE 327 daily, while 20 patients will receive treatment three times per week.
  • Burn wound specialists will oversee delivery of RECCE 327 in a spray-on formulation, specifically developed for the study.

EU-JAMRAI urges governments and stakeholders to find a sustainable commitment to fight Antimicrobial Resistance

Retrieved on: 
Friday, February 12, 2021
Articles, Pharmaceuticals policy, Health sciences, Antimicrobial resistance, Evolutionary biology, Veterinary medicine, Sarah Wiener, Antimicrobial, Life sciences

MADRID, Feb. 12, 2021 /PRNewswire/ -- We are handing over the beginning rather than the end in the fight against Antimicrobial Resistance (AMR).

Key Points: 
  • MADRID, Feb. 12, 2021 /PRNewswire/ -- We are handing over the beginning rather than the end in the fight against Antimicrobial Resistance (AMR).
  • Participants urged the European Commission, governments and stakeholders to demonstrate a sustainable commitment to tackle this global threat to public health.
  • Some keynote speakers were Charles Price, DG Sant (European Commission); Danilo Lo Fo Wong, Programme Manager, Antimicrobial Resistance (World Health Organization); or Sarah Wiener, Chair of MEP Interested Group on AMR.
  • 2Practical, evidence-based approach which prevents patients and health workers from being harmed by avoidable infection and as a result of antimicrobial resistance (source: WHO).

Number of Epic Supported Mass Vaccination Sites Reaches 100

Retrieved on: 
Thursday, February 11, 2021
Medical specialties, Medicine, Veterinary medicine, Biotechnology, Vaccination, Novant Health, Cowpox, Vaccination policy

VERONA,Wis., Feb. 11, 2021 /PRNewswire/ -- Epic announced that it is supporting 100 sites running community-based mass vaccination locations across the country.

Key Points: 
  • VERONA,Wis., Feb. 11, 2021 /PRNewswire/ -- Epic announced that it is supporting 100 sites running community-based mass vaccination locations across the country.
  • Across the entire Epic community, including both mass vaccination sites and traditional clinical settings, Epic software is being used to administer approximately 500,000 vaccinations daily.
  • This is a companion effort to the Biden-Harris Administration's plan to help set up 100 federally supported vaccination centers by the end of February.
  • Examples of mass vaccination sites supported by Epic include:
    Novant Health (NC):Novant Health is using Epic to schedule vaccinations across their footprint, including mass vaccination sites and community pop-up events.

'Supercharger' to revive mainstay antibiotic in global fight against antibiotic resistance

Retrieved on: 
Thursday, February 11, 2021
Health sciences, Health, Articles, Pharmaceuticals policy, Veterinary medicine, Antibiotics, Evolutionary biology, Antimicrobial resistance, Drug resistance, Vancomycin, Antimicrobial, Production of antibiotics

Offering new hope in the plight against antimicrobial resistance (AMR), STM has applied its patented permeator technology to the widely used antibiotic vancomycin through a process of "intelligent repurposing".

Key Points: 
  • Offering new hope in the plight against antimicrobial resistance (AMR), STM has applied its patented permeator technology to the widely used antibiotic vancomycin through a process of "intelligent repurposing".
  • The technology, originally developed at Stanford University, attaches easily to the existing antibiotic.
  • The modified antibiotic can effectively penetrate into urgent threat bacterial pathogens allowing a highly effective eradication of superbugs.
  • "Antibiotic-resistant infections are a serious threat to global health and with only four new classes of antibiotics introduced since the early 1960s, clinicians just don't have enough to work with.

Pets Lend a Paw to Help Students in Veterinary Science CTE Classes During Remote Learning

Retrieved on: 
Thursday, February 11, 2021
Primary, Secondary, Education, Health, Consumer, Teens, Training, Veterinary, Intersession, Veterinarian, Veterinary medicine, Articles

View the full release here: https://www.businesswire.com/news/home/20210211005263/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210211005263/en/
    Learn4Life Veterinary Sciences students Cayla P. (left) and Lunden G. (right) learn how to treat patients with help from their pets.
  • (Photo: Business Wire)
    The Veterinary Science pathway is a tough, 30-week program but popular with Learn4Life students.
  • February is CTE Month, celebrating the value of CTE classes that help high school graduates on their way to a high-demand, high-paying career.
  • Serving more than 47,000 students including full-time and intersession students we help them prepare for a future beyond high school.

App State and Banfield Pet Hospital® Announce New Online Vet Tech Program Aimed at Addressing Veterinary Shortage

Retrieved on: 
Wednesday, February 10, 2021
Paraveterinary workers, Technicians, Banfield Pet Hospital, Veterinarian, Sheri Everts, Banfield, Veterinary medicine, Health, Articles, Occupations

As part of the partnership, Banfield made a multi-million-dollar commitment towards the development of a new 4-year online degree program at App State for Licensed Veterinary Technicians (LVTs).

Key Points: 
  • As part of the partnership, Banfield made a multi-million-dollar commitment towards the development of a new 4-year online degree program at App State for Licensed Veterinary Technicians (LVTs).
  • "App State excels in developing visionary academic programs that address professional workforce shortages in rural communities and help advance industry standards," Chancellor Sheri Everts said.
  • The App State Online program will be housed in the university's College of Arts & Sciences and will combine Bachelor of Science credentials with preparation for veterinary technician licensure.
  • More than 3,600 Banfield veterinarians are committed to providing high-quality veterinary care to over three million pets annually.

Global Antibiotics Partnering Deals Directory 2020: Access to Headline, Upfront, Milestone and Royalty Data / Case Studies of Real-Life Antibiotics Deals

Retrieved on: 
Tuesday, February 9, 2021
Health sciences, Antibiotic, Health, Antibiotic resistance, Pharmaceuticals policy, Veterinary medicine, Life sciences, Evolutionary biology, Meat industry

DUBLIN, Feb. 9, 2021 /PRNewswire/ -- The "Global Antibiotics Partnering Terms and Agreements 2010 to 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 9, 2021 /PRNewswire/ -- The "Global Antibiotics Partnering Terms and Agreements 2010 to 2020" report has been added to ResearchAndMarkets.com's offering.
  • The Global Antibiotics Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.
  • The report provides a detailed understanding and analysis of how and why companies enter antibiotics partnering deals.
  • Global Antibiotics Partnering Terms and Agreements 2010 to 2020 includes:
    In Global Antibiotics Partnering Terms and Agreements 2010 to 2020, the available contracts are listed by:

Phibro Animal Health Corporation to Participate in the Barclays Virtual Global Healthcare Conference

Retrieved on: 
Monday, February 8, 2021
Communications, Health, Other Health, General Health, Public relations, Investor relations, Veterinary, Animal diseases, Veterinary medicine, Veterinarian, Phibro, Barclays, Food, Companies, Service companies, Financial services

Phibro Animal Health Corporation (NASDAQ:PAHC) announced it will participate in the Barclays Virtual Global Healthcare Conference.

Key Points: 
  • Phibro Animal Health Corporation (NASDAQ:PAHC) announced it will participate in the Barclays Virtual Global Healthcare Conference.
  • The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com .
  • Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce healthy, affordable food while using fewer natural resources.
  • Our filings with the Securities and Exchange Commission are available online at www.sec.gov , www.pahc.com or on request from the company.

FDA Announces New Resource for Veterinarians and Pet Owners Interested in Clinical Field Studies of Animal Cells, Tissues, and Cell- and Tissue-Based Products

Retrieved on: 
Monday, February 8, 2021
Health, Articles, Food and Drug Administration, United States Public Health Service, Veterinary physician, Clinical trial, Veterinary medicine, Veterinary pathology

Today, the U.S. Food and Drug Administration is announcing a listing of clinical field studies that are investigating Animal Cells, Tissues, and Cell- and Tissue-Based Products (ACTPs) in veterinary patients.

Key Points: 
  • Today, the U.S. Food and Drug Administration is announcing a listing of clinical field studies that are investigating Animal Cells, Tissues, and Cell- and Tissue-Based Products (ACTPs) in veterinary patients.
  • The webpage provides animal owners, veterinarians, researchers and the public with information on clinical field studies that are being investigated for the use of ACTPs in veterinary patients.
  • Connecting interested pet owners and their veterinary teams with relevant clinical studies also helps sponsors in generating data toward potential FDA approval.
  • At the time of listing, the information is intended to disclose clinical field studies in support of product development and FDA approval.